**1. Introduction**

422 Breast Cancer – Focusing Tumor Microenvironment, Stem Cells and Metastasis

Uberti B, Dentelli P, Rosso A, Defilippi P, Brizzi MF (2010) Inhibition of beta1 integrin and

van der Flier S, van der Kwast TH, Claassen CJ, Timmermans M, Brinkman A, Henzen-

Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA *et al* (2000).

Wendt MK, Smith JA, Schiemann WP (2009). p130Cas is required for mammary tumor

Wu H, Parsons JT (1993). Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. *J Cell Biol* 120: 1417-26. Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT (1991). Identification and

Yarden Y, Baselga J, Miles D (2004). Molecular approach to breast cancer treatment. *Semin* 

Zhang XA, He B, Zhou B, Liu L (2003). Requirement of the p130CAS-Crk coupling for

with F-actin and the Arp2/3 complex. *J Cell Biol* 151: 29-40.

regulation of Smad2/3 activity. *J Biol Chem* 284: 34145-56.

6581-90.

172-8.

11: 5113-24.

*Oncol* 31: 6-13.

*Chem* 278: 27319-28.

IL-3Rbeta common subunit interaction hinders tumour angiogenesis. *Oncogene* 29:

Logmans SC *et al* (2001). Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue. *Int J Biol Markers* 16:

Cortactin localization to sites of actin assembly in lamellipodia requires interactions

growth and transforming growth factor-beta-mediated metastasis through

characterization of a novel cytoskeleton-associated pp60src substrate. *Mol Cell Biol*

metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. *J Biol* 
